Teosyal® Puresense Redensity II

What it is

Teosyal Redensity II is a hyaluronic acid gel specifically developed to treat the sensitive eye area, including the tear trough and the area under the eyes.

Mechanism of action

The hyaluronic acid (15 mg/ml, low cross-linking < 10 %) replaces lost volume and improves hydration, and the formulation additionally contains amino acids, antioxidants, minerals and vitamin B6. The gel has low hygroscopicity, meaning it attracts little fluid and gives a lower risk of swelling after treatment.

Indications and treatment areas

Periorbital area: tear trough, palpebromalar groove, eyebrows, outer canthus and crow's feet, as well as the nasojugal groove.

Treatment protocol

• Comfort: 0.3 % lidocaine integrated into the formulation for a more comfortable injection.
• Gel properties: sterile, non-pyrogenic and transparent, with a viscoelasticity adapted to the area around the eye.

Expected results

Reduced hollow tear trough, restored volume and improved skin hydration in the eye area, with a low risk of swelling. Estimated duration at least 12 months.

Documentation and traceability

CE-marked medical device, manufactured by Teoxane (Switzerland).

Sammensetning: 15 mg/ml hyaluronsyre, 8 aminosyrer (glysin, lysin, treonin, prolin, isoleucin, leucin, valin, arginin), 3 antioksidanter (glutation, N-acetyl-L-cystein, alfa-liponsyre), 2 mineraler (sink, kobber), vitamin B6, og 0,3 % lidokain — 2 × 1 ml sprøyter per pakning.

Dette komplette næringskomplekset er utviklet for å restrukturere, beskytte og fukte den sarte huden rundt øynene, med lidokain inkludert for en mer komfortabel behandling.

Injiseres langsomt i varierende dybde – intradermalt, subkutant eller på periost – i det periorbitale området (tear trough, palpebromalar fure, øyenbryn, ytre canthus) og nasojugal fure. Maks 6 ml per seanse. 2 × 1 ml sprøyter; 2 × 30G ½″ nåler per sprøyte medfølger. Kan alternativt settes med 25G stump kanyle. Inneholder 0,3 % lidokain.